Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person25
Edesa Biotech, Inc.
Company
NKGen Biotech, Inc.
Company
XBiotech Inc.
Company
Krystal Biotech, Inc.
Company
Fortress Biotech, Inc.
Company
Moleculin Biotech, Inc.
Company
ONCOLYTICS BIOTECH INC
Company
PharmaCyte Biotech, Inc.
Company
GOLDENWELL BIOTECH, INC.
Company
Vir Biotechnology, Inc.
Company
MAIA Biotechnology, Inc.
Company
Sana Biotechnology, Inc.
Company
PUMA BIOTECHNOLOGY, INC.
Company
BIODESIX INC
Company
ESS Tech, Inc.
Company
BiomX Inc.
Company
CitroTech Inc.
Company
Nautilus Biotechnology, Inc.
Company
BIOTRICITY INC.
Company
BIOGEN INC.
Company
BIOVIE INC.
Company
BioAtla, Inc.
Company
GRI Bio, Inc.
Company
FDCTECH, INC.
Company
Q32 Bio Inc.
Company
Primary record5
Edesa Biotech, Inc. filed 4
SEC form 4 filed by Edesa Biotech, Inc. (CIK 1540159) on 2026-11-05.
Edesa Biotech, Inc. filed SCHEDULE 13G/A
0001104659-26-122821.txt : 20261104 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001319244 XXXXXXXX LIVE 1 Common Shares, without par value 09/30/2026 0001540159 Edesa Biotech, Inc. 27966L306 100 Spy Court Mark
Edesa Biotech, Inc. filed 4
SEC form 4 filed by Edesa Biotech, Inc. (CIK 1540159) on 2026-10-29.
Edesa Biotech, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 23, 2026, the Board of Directors (the “Board”) of Ed
Edesa Biotech, Inc. filed 8-K
Item 8.01. Other Events. On October 15, 2026, Edesa Biotech, Inc. (the Company ) reported that the U.S. Food and Drug Administration ( FDA ) has cleared the Company's Investigational New Drug ( IND ) application for its